APA

Merchant M., Ma X., Maun H. R., Zheng Z., Peng J., Romero M., Huang A., Yang N., Nishimura M., Greve J., Santell L., Zhang Y., Su Y., Kaufman D. W., Billeci K. L., Mai E., Moffat B., Lim A., Duenas E. T., Phillips H. S., Xiang H., Young J. C., Vande Woude G. F., Dennis M. S., Reilly D. E., Schwall R. H., Starovasnik M. A., Lazarus R. A. & Yansura D. G. (20131104). Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Merchant Mark, Ma Xiaolei, Maun Henry R, Zheng Zhong, Peng Jing, Romero Mally, Huang Arthur, Yang Nai-ying, Nishimura Merry, Greve Joan, Santell Lydia, Zhang Yu-Wen, Su Yanli, Kaufman Dafna W, Billeci Karen L, Mai Elaine, Moffat Barbara, Lim Amy, Duenas Eileen T, Phillips Heidi S, Xiang Hong, Young Judy C, Vande Woude George F, Dennis Mark S, Reilly Dorothea E, Schwall Ralph H, Starovasnik Melissa A, Lazarus Robert A and Yansura Daniel G. 20131104. Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Merchant M., Ma X., Maun H. R., Zheng Z., Peng J., Romero M., Huang A., Yang N., Nishimura M., Greve J., Santell L., Zhang Y., Su Y., Kaufman D. W., Billeci K. L., Mai E., Moffat B., Lim A., Duenas E. T., Phillips H. S., Xiang H., Young J. C., Vande Woude G. F., Dennis M. S., Reilly D. E., Schwall R. H., Starovasnik M. A., Lazarus R. A. and Yansura D. G. (20131104). Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Merchant Mark, Ma Xiaolei, Maun Henry R, Zheng Zhong, Peng Jing, Romero Mally, Huang Arthur, Yang Nai-ying, Nishimura Merry, Greve Joan, Santell Lydia, Zhang Yu-Wen, Su Yanli, Kaufman Dafna W, Billeci Karen L, Mai Elaine, Moffat Barbara, Lim Amy, Duenas Eileen T, Phillips Heidi S, Xiang Hong, Young Judy C, Vande Woude George F, Dennis Mark S, Reilly Dorothea E, Schwall Ralph H, Starovasnik Melissa A, Lazarus Robert A and Yansura Daniel G. Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent. : Proceedings of the National Academy of Sciences of the United States of America. 20131104.